120 related articles for article (PubMed ID: 31464247)
21. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.
Molina R; Jo J; Filella X; Zanon G; Pahisa J; Mu noz M; Farrus B; Latre ML; Escriche C; Estape J; Ballesta AM
Breast Cancer Res Treat; 1998 Sep; 51(2):109-19. PubMed ID: 9879773
[TBL] [Abstract][Full Text] [Related]
22. Measurement of tumor markers in chronic hemodialysis patients.
Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
[TBL] [Abstract][Full Text] [Related]
23. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
24. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.
Uehara M; Kinoshita T; Hojo T; Akashi-Tanaka S; Iwamoto E; Fukutomi T
Int J Clin Oncol; 2008 Oct; 13(5):447-51. PubMed ID: 18946756
[TBL] [Abstract][Full Text] [Related]
25. Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer.
Louhimo J; Alfthan H; Stenman UH; Haglund C
Oncology; 2004; 66(2):126-31. PubMed ID: 15138364
[TBL] [Abstract][Full Text] [Related]
26. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3.
Bassi C; Salvia R; Gumbs AA; Butturini G; Falconi M; Pederzoli P
Langenbecks Arch Surg; 2002 Nov; 387(7-8):281-5. PubMed ID: 12447553
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer.
Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
Ann Oncol; 2013 May; 24(5):1225-31. PubMed ID: 23230137
[TBL] [Abstract][Full Text] [Related]
28. Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.
Ercan Ş; Kaymaz Ö; Yücel N; Orçun A
Arch Gynecol Obstet; 2012 Mar; 285(3):579-84. PubMed ID: 21792548
[TBL] [Abstract][Full Text] [Related]
29. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
30. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
[TBL] [Abstract][Full Text] [Related]
31. [Tumour markers in chronic kidney disease].
Mercadal L
Nephrol Ther; 2015 Apr; 11(2):122-4. PubMed ID: 25709104
[TBL] [Abstract][Full Text] [Related]
32. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
33. Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.
Halme L; Kärkkäinen P; Isoniemi H; Mäkisalo H; von Bogulawski K; Höckerstedt K
Scand J Gastroenterol; 1999 Apr; 34(4):426-31. PubMed ID: 10365905
[TBL] [Abstract][Full Text] [Related]
34. Comparison of bone scintigraphy with serum tumor markers of CA 15-3 and carcinoembryonic antigen in patients with breast carcinoma.
Gedik GK; Kiratli PO; Tascioglu B; Aras T
Saudi Med J; 2006 Mar; 27(3):317-22. PubMed ID: 16532090
[TBL] [Abstract][Full Text] [Related]
35. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
[TBL] [Abstract][Full Text] [Related]
36. [Tumor markers in dialysis-dependent renal failure. A comparison of the mucin-like carcinoma antigen, CA 15-3, CA 125, CA 19-9 and CEA antigens].
Ammon A; Eiffert H; Weber MH; Rummel J; Niemann J
Onkologie; 1988 Dec; 11(6):260-2. PubMed ID: 3071760
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
40. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
